ArticleCancer chemotherapy and pharmacology2010

Phase I trial of non-cytotoxic suramin as a modulator of docetaxel and gemcitabine therapy in previously treated patients with non-small cell lung cancer.

Elaine T Lam et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.